Significant Ownership of Opaleye Management Inc.

Signature - Title
/s/ James Silverman - President
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Opaleye Management Inc..

Notify me when Opaleye Management Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Opaleye Management Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SLGL Sol-Gel Technologies Ltd Ordinary Shares, par value NIS 1.00 per share. 13% $13,482,369 +$5,964,924 367,367 +79% Opaleye Management Inc. 13 Nov 2025
ACOG Alpha Cognition Inc. Common Stock, no par value 9.5% $13,460,096 +$1,271,673 2,070,784 +10% Opaleye Management Inc. 31 Dec 2025
KPTI Karyopharm Therapeutics Inc. Common Stock, no par value 9.5% $10,262,842 1,569,002 Opaleye Management Inc. 10 Oct 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 7.6% $787,500 750,000 Opaleye Management, Inc. 31 Dec 2024
CDXS Codexis, Inc. Common Stock, par value $0.0001 per share 7.5% $11,067,273 -$3,583,149 6,789,738 -24% Opaleye Management Inc. 31 Dec 2025
RZLT Rezolute, Inc. Common Stock 5.3% $46,967,324 4,912,900 Opaleye Management Inc. 12 Dec 2025
LRMR Larimar Therapeutics, Inc. Common Stock 4.8% $15,412,500 +$590,966 4,110,000 +4% Opaleye Management, Inc. 29 Aug 2025
TARA Protara Therapeutics, Inc. Common Stock 4.7% $7,473,600 -$410,400 1,730,000 -5.2% Opaleye Management, Inc. 31 Mar 2025
OCUL OCULAR THERAPEUTIX, INC Common Stock, par value $0.0001 per share 2.8% $34,305,750 4,342,500 Opaleye Management Inc. 31 Dec 2024
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 Opaleye Management Inc. 31 Dec 2024

Schedules 13D/G Reported by Opaleye Management Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.